R. Kent McGaughy Jr., Director, 10% Owner at REATA PHARMACEUTICALS INC (RETA), bought 278,275 shares at $24.88 ($6.9M) on 2017-12-13, disclosed to the SEC on 2017-12-15.
Open-market purchase of $6.9M RETA by Director, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $23.98 | 300 | $7K | 0.1% |
| 2 | $24.88 | 121,425 | $3.0M | 43.9% |
| 3 | $24.65 | 78,275 | $1.9M | 28.0% |
| 4 | $24.65 | 78,275 | $1.9M | 28.0% |
| Total | $24.75 avg | 278,275 | $6.9M | 100% |
| Filing → |
| TIL | BUY | 2021-03-25 | $9.0M | — | Filing → |
| APEN | BUY | 2020-07-21 | $2.2M | — | Filing → |
| RETA | BUY | 2019-11-18 | $7.4M | — | Filing → |